Medicine taking behaviour in depression - Part 1

Progress in Neurology and Psychiatry

Volumn 13, Issue 1, 2009, Pages 21-23

  Feetam, Celia ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ANXIETY; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONSULTATION; DEPRESSION; DOCTOR PATIENT RELATION; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; GENERAL PRACTICE; HUMAN; MORBIDITY; NAUSEA; OPTIMAL DRUG DOSE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; SEXUAL DYSFUNCTION; SIDE EFFECT; SUICIDE; WEIGHT GAIN;

EID: 63249118371     PISSN: 13677543     EISSN: None     Source Type: Journal    
DOI: 10.1002/pnp.108     Document Type: Article

References (28)

1. National Institute for Health and Clinical Excellence: Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. January 2009.www.nice.org.uk/Guidance/CG76 Accessed 3rd February 2009.
2. Haynes RB,Yao X, Degani A, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2000, Issue 1 Art No; Cd000011. DOI:10,=.1002/14651858. Cd000011. pub2.
3. Bruer JT. Methodological rigor and citation frequency in patient compliance literature. Am J Pub Health 1982;72:1119-23.
4. National Institute for Health and Clinical Excellence: Medicines Concordance and adherence;involving adults and carers in decisions about prescribed medicines:Responses to stakeholder scope consultation comments:14th June 2007.www.nice.org.uk Accessed 12 March 2008.
5. Myers ED, Braithwaite A. Outpatient compliance with antidepressant medication. Br J Psychiatry 1992;160:83-6.
6. Olfson M, Marcus SC,Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006;16:101-8.
7. Bambauer KZ,Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med 2006:166;498-504.
8. Maddox JC,Levi M,Thompson C.The compliance with antidepressants in general practice. J Physopharmacol 1994;8:48-53.
9. Lin EH,Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy, Med Care 1995;33:67-74.
10. National Institute for Health and Clinical Excellence; Depression: management of depression in primary and secondary care. Clinical Guideline (amended) December 2004 with amendment April 2007.www.nice.org.uk Accessed 12 March 2008.
11. Geddes JR, Carney SM,Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-61.
12. MacEwan WG,Remick RA.Treatment resistant depression: a clinical perspective. Can J Psychiatry 1988;33:788-92.
13. Souery D, Mendlewicz J. Compliance and therapeutic issues in resistant depression. Int J Clin Psychopharmacol 1998(suppl 2):513-8.
14. Wiess JJ, Gorman MD. Antidepressant adherence and suicide risk in depressed youth. Letter to the editor. Am J Psychiatry 2005;162:1756-7.
15. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;43:27-39.
16. Vergouwen ACM,Bakker A, Katon WJ, et al. Improving adherence to antidepressants. A systematic review. J Clin Psychiatry 2003;64:1415-20.
17. Demyttenaere K, Bruffaerts R, Albert A, et al. Development of an antidepressant compliance questionnaire. Acta Psychiatr Scand 2004;110:201-7.
18. Peveler R,George C,Kinmonth AL,et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomized controlled trial. BMJ 1999;319:612-5.
19. George CF, Peveler RC, Heiliger S, et al. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000:50(2);66-71.
20. Gehi A, Haas D, Pipkin S, et al. Depression and medication adherence in outpatients with coronary heart disease. Arch Int Med 2005;165:2508-13.
21. DiMatteo MR, Lepper HS, Croghan RW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med 2000;60 (14):2101-7.
22. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting: 1; beyond lack of efficacy and adverse effects. J Clin Psychiatry 2001;62 (suppl. 22):30-3.
23. Ashton AK,Jarnerson BD,Weinstein WL,et al.Antidepressant-related adverse effects impacting treatment compliance:Results of a patients survey.Curr Ther Res 2005;66(2):96-106.
24. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002;288:1403-9.
25. Aikens JE, et al.Adherence to maintenance phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 2005;3:23-30.
26. Badger F, Nolan P. Concordance with antidepressant medication in primary care. Nurs Stand 2006;20(52):35-40.
27. Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997;58 (Suppl.1):4-8.
28. Gardener DM,Mackinnin N,Langille DB, et al.A comparison of factors used by physicians and patients in the selection of antidepressant agents. Psychiatric Services 2007;58: 34-40.